Malarone Alternatives Compared
| Malarone (atovaquone / proguanil) | Doxycycline | Atovaquone / proguanil |
|
|---|
| Malarone (atovaquone / proguanil) | Doxycycline | Atovaquone / proguanil |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Malaria Prevention, Malaria. Malarone may also be used for purposes not listed in this medication guide. |
Prescription only
Doxycycline is an effective antibiotic that treats a wide range of infections. However, it is not usually recommended for children aged less than eight or pregnant women in the last half of their... View more |
Prescription only
Prescribed for Malaria Prevention, Malaria. Atovaquone / proguanil may also be used for purposes not listed in this medication guide. |
Related suggestions Malaria Prevention (Malaria Prophylaxis)
Popular comparisons
|
|||||||||||||||||||||||
| More about Malarone (atovaquone / proguanil) | More about Doxycycline | More about Atovaquone / proguanil | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Malarone has an average rating of 5.5 out of 10 from a total of 45 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 40% reported a negative effect. |
Doxycycline has an average rating of 6.4 out of 10 from a total of 1643 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 27% reported a negative effect. |
Atovaquone / proguanil has an average rating of 5.2 out of 10 from a total of 50 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Malarone side effects |
View all Doxycycline side effects |
View all Atovaquone / proguanil side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Malarone prices |
View all Doxycycline prices |
View all Atovaquone / proguanil prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other atovaquone / proguanil brands include: Malarone Pediatric | Acticlate, Adoxa, Adoxa CK, Adoxa Pak, Adoxa TT, Alodox, Avidoxy, Doryx, Doryx MPC, Doxy 100, Doxy 200, Doxy-Caps, Doxy-D, LymePak, Mondoxyne NL, Monodox, Morgidox, Okebo, Oracea, Oraxyl, Targadox, Uracil, Vibramycin View more | Malarone, Malarone Pediatric | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
60.5 hours |
23 hours |
60.5 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 125 drugs are known to interact with Malarone:
|
A total of 237 drugs are known to interact with Doxycycline:
|
A total of 125 drugs are known to interact with Atovaquone / proguanil:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
July 14, 2000 |
December 05, 1967 |
July 14, 2000 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.